INTUITIVE SURGICAL INC (ISRG) Factsheet
INTUITIVE SURGICAL INC (ISRG) Stock Analysis
Analysis from 10-Q filed 2025-10-22. Data as of Q1 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC 15.4%. FCF margin 26.8%. D/E 0.0x. Source: 10-Q filed 2025-10-22.
| Metric | Value | Context |
|---|---|---|
| ROIC | 15.4% | Solid returns |
| FCF Margin | 26.8% | Strong cash generation |
| Debt/Equity | 0.0x | Conservative leverage |
ROIC 15.4% — Top 25% of sector peers. FCF margin 26.8% — Top 5%.
Explore INTUITIVE SURGICAL INC: Earnings History | Filings | ROIC Analysis
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for ISRG: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_changes, get_metric_history, compare_companies, screen_filing_signals.
Profitability: INTUITIVE SURGICAL INC earns 15.4% ROIC, Top 25% in Healthcare
ROIC TTM 15.4%, sector median -2.8%, Top 25%. DuPont: NOPAT margin 25.5% × asset turnover 0.5x. Gross margin 66.3%. Operating margin 30.5%. Source: 10-Q filed 2025-10-22.
| Metric | ISRG | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 15.4% | Good | Above sector median of -2.8% |
| Return on Equity (ROE) | 17.1% | Good | Efficient use of shareholder equity |
| Gross Margin | 66.3% | Excellent | Strong pricing power |
| Operating Margin | 30.5% | Excellent | Efficient operations |
Cash Flow: INTUITIVE SURGICAL INC generates $2.8B FCF at 26.8% margin, positive NaN/8 quarters
FCF TTM $2.8B. FCF margin 26.8%, Top 5%. OCF/Net income 1.1x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2025-10-22.
| Metric | ISRG | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 26.8% | Excellent | Excellent cash conversion |
| Free Cash Flow (TTM) | $2.8B | Good | Positive cash generation |
| OCF/Net Income | 1.1x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: INTUITIVE SURGICAL INC at 0.0x leverage
Debt/Equity 0.0x. Source: 10-Q filed 2025-10-22.
| Metric | ISRG | Rating | Context |
|---|---|---|---|
| Debt to Equity | 0.0x | Excellent | Conservative capital structure |
Valuation: INTUITIVE SURGICAL INC trades at 55.1x earnings
P/E 55.1x. EV/Sales 15.0x. FCF yield 1.7%. Source: 10-Q filed 2025-10-22.
| Metric | ISRG | Rating | Context |
|---|---|---|---|
| P/E Ratio | 55.1x | Warning | Premium valuation |
| EV/Sales | 15.0x | Warning | Growth premium priced in |
| FCF Yield | 1.7% | Warning | Lower cash yield |
Capital Allocation: INTUITIVE SURGICAL INC returns 2.1% shareholder yield
Total shareholder yield 2.1% (buyback 2.1%). Capital returned $3.4B TTM. Source: 10-Q filed 2025-10-22.
| Metric | ISRG | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 2.1% | Adequate | Dividend + buyback yield combined |
| Buyback Yield | 2.1% | Adequate | Active share repurchases |
| Total Capital Returned (TTM) | $3.4B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 15.4% | Top 25% | - |
| Free Cash Flow Margin | 26.8% | Top 5% | - |
| Gross Margin | 66.3% | Top 50% | 1.0x above |
| Operating Margin | 30.5% | Top 25% | 13.4x above |
| Return on Equity (ROE) | 17.1% | Top 25% | - |
| P/E Ratio | 55.1x | N/A | - |
Financial Scorecard
| Metric | ISRG | Rating | Sector Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 15.4% | Good | Top 25% of sector (median: -2.8%) |
| Free Cash Flow Margin | 26.8% | Excellent | Top 5% of sector (median: 0.0%) |
| Gross Margin | 66.3% | Excellent | Top 50% of sector (median: 63.7%) |
| Debt to Equity Ratio | 0.0% | Excellent | Conservative capital structure |
| P/E Ratio (Price-to-Earnings) | 55.1x | Warning | High expectations priced in |
| Free Cash Flow Yield | 1.7% | Warning | Growth-focused valuation |
Frequently Asked Questions
Q: What is INTUITIVE SURGICAL INC's Return on Invested Capital (ROIC)?
INTUITIVE SURGICAL INC (ISRG) has a trailing twelve-month Return on Invested Capital (ROIC) of 15.4%. Sector median -2.8%. Source: 10-Q filed 2025-10-22.
Q: What is INTUITIVE SURGICAL INC's Free Cash Flow Margin?
INTUITIVE SURGICAL INC (ISRG) has a free cash flow margin of 26.8%, generating $2.8 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2025-10-22.
Q: What is INTUITIVE SURGICAL INC's P/E ratio and how does it compare to peers?
INTUITIVE SURGICAL INC (ISRG) trades at a P/E ratio of 55.1x, which is above the sector median of N/A. EV/Sales 15.0x. FCF yield 1.7%. Source: 10-Q filed 2025-10-22.
Q: What is INTUITIVE SURGICAL INC's revenue and earnings growth?
INTUITIVE SURGICAL INC (ISRG) grew revenue by 21.4% year-over-year. EPS +20.6% YoY. Source: 10-Q filed 2025-10-22.
Q: Is INTUITIVE SURGICAL INC buying back stock?
INTUITIVE SURGICAL INC (ISRG) repurchased $3.4 billion of stock over the trailing twelve months. This represents a buyback yield of 2.1%. Source: 10-Q filed 2025-10-22.
Q: How does INTUITIVE SURGICAL INC compare to competitors in Healthcare?
Compared to other companies in Healthcare, INTUITIVE SURGICAL INC (ISRG) shows: ROIC 15.4%, sector median -2.8% (Top 25%). FCF margin 26.8%, sector median 0.0% (Top 5%). Gross margin 66.3%, 2.6pp above sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with INTUITIVE SURGICAL INC?
No quantitative warning flags fired for INTUITIVE SURGICAL INC (ISRG) on margin trend, FCF trend, ROIC trend, or leverage thresholds. Source: 10-Q filed 2025-10-22.
Data Source: Data sourced from 10-Q filed 2025-10-22. TTM metrics as of Q1 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.